<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Stockwatch - Key Events</title>
    <link>https://www.stockwatch.live/</link>
    <description>Real-time corporate announcements, deals, and financial results.</description>
    <lastBuildDate>Tue, 13 Jan 2026 04:01:33 +0000</lastBuildDate>
    <language>en-in</language>
    <atom:link href="https://api.stockwatch.live/api/keyEvents" rel="self" type="application/rss+xml" />
    
    <item>
      <title>[BALUFORGE] Balu Forge Industries: No Adverse Impact After Income Tax Department Search</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Balu+Forge+Industries+Ltd&title=Balu+Forge+Industries%3A+No+Adverse+Impact+After+Income+Tax+Department+Search&newsId=c64e8097-a65b-4055-9211-3886783b2f1e&token=YzY0ZTgwOTctYTY1</link>
      <guid isPermaLink="false">c64e8097-a65b-4055-9211-3886783b2f1e</guid>
      <pubDate>Tue, 13 Jan 2026 03:48:58 +0000</pubDate>
      <category>Legal</category>
      <description><![CDATA[<p>Balu Forge Industries Ltd. has notified that the Income Tax Department conducted a search at some of their offices and manufacturing units on 07th January, 2026. The search concluded on 13th January, 2026 with no incriminating documents found or seized. The business operations and production were not impacted, and there is no material adverse impact on the financial position of the company. The company continues to cooperate with the Department and adheres to the highest standards of ethical conduct and legal compliance.</p><ul><li>Income Tax Department conducted a search at Balu Forge Industries Ltd. offices and manufacturing units</li><li>The search concluded on 13th January, 2026 with no incriminating documents found or seized</li><li>Business operations and production were not impacted by the search</li><li>No material adverse impact on the financial position of the company</li><li>Balu Forge Industries Ltd. continues to cooperate with the Income Tax Department and adheres to ethical conduct and legal compliance</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/707a9c8e-9d6a-4a1b-ad8d-78242708d7e5.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Balu Forge Industries Ltd | Category: Legal</small>]]></description>
    </item>
    <item>
      <title>[METROPOLIS] Metropolis Healthcare Launches Centre of Genomics to Advance Precision Diagnostics and Research in India</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Metropolis+Healthcare+Ltd&title=Metropolis+Healthcare+Launches+Centre+of+Genomics+to+Advance+Precision+Diagnostics+and+Research+in+India&newsId=73900ae7-8522-4180-8fa5-2f067881597e&token=NzM5MDBhZTctODUy</link>
      <guid isPermaLink="false">73900ae7-8522-4180-8fa5-2f067881597e</guid>
      <pubDate>Tue, 13 Jan 2026 03:21:11 +0000</pubDate>
      <category>New Launch</category>
      <description><![CDATA[<strong>ðŸ”¥ Trending</strong><br/><p>Metropolis Healthcare Limited, led by Ameera Shah, has announced the launch of its Centre of Genomics. The centre, supported by two CAP-accredited genomics labs in Delhi NCR and Mumbai, aims to deliver clinically actionable genomic insights across multiple high-impact clinical specialties. The Centre of Genomics is equipped with Illuminaâ€™s NovaSeqâ„¢ X Series for research purposes, offering unmatched throughput, accuracy, and sustainability. The centre plans to expand its genomic portfolio to 500+ advanced tests across key clinical specialties, focusing on oncology, reproductive health, neurology, transplant immunology, and rare diseases.</p><ul><li>Launch of Centre of Genomics by Metropolis Healthcare Limited</li><li>Supported by two CAP-accredited genomics labs in Delhi NCR and Mumbai</li><li>Equipped with Illuminaâ€™s NovaSeqâ„¢ X Series for research purposes</li><li>Plans to expand genomic portfolio to 500+ advanced tests across key clinical specialties</li><li>Focus on high-impact clinical specialties including oncology, reproductive health, neurology, transplant immunology, and rare diseases</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/d7abd802-b9d0-418b-b77c-c440d8f88b19.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Metropolis Healthcare Ltd | Category: New Launch</small>]]></description>
    </item>
    <item>
      <title>[NETRIPPLES] Trading Window Closed for Netripples Software Ltd&apos;s 1st Quarter Results Board Meeting</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Netripples+Software+Ltd&title=Trading+Window+Closed+for+Netripples+Software+Ltd%27s+1st+Quarter+Results+Board+Meeting&newsId=a27edb86-98eb-4c2a-8cb6-533556946475&token=YTI3ZWRiODYtOThl</link>
      <guid isPermaLink="false">a27edb86-98eb-4c2a-8cb6-533556946475</guid>
      <pubDate>Tue, 13 Jan 2026 03:07:55 +0000</pubDate>
      <category>Board Meeting</category>
      <description><![CDATA[<p>Netripples Software Ltd has announced the closure of the trading window for the 1st Quarter Results Board Meeting. The meeting is scheduled for 21st January 2026, and accordingly, the trading window will be closed from 14th January 2026 to 24th January 2026. The announcement was made through a letter uploaded on the company&apos;s website, www.netripples.com.</p><ul><li>Trading window closed for Netripples Software Ltd&apos;s 1st Quarter Results Board Meeting</li><li>Board Meeting scheduled for 21st January 2026</li><li>Trading window closure from 14th January 2026 to 24th January 2026</li><li>Announcement made through a letter on the company&apos;s website</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/95bfea5c-85c9-4d48-a1a7-87624e3f3e2e.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Netripples Software Ltd | Category: Board Meeting</small>]]></description>
    </item>
    <item>
      <title>[NETRIPPLES] Netripples Software Ltd Reports No Related Party Transactions for 3rd Quarter of FY 2025-26</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Netripples+Software+Ltd&title=Netripples+Software+Ltd+Reports+No+Related+Party+Transactions+for+3rd+Quarter+of+FY+2025-26&newsId=89e14e14-d9de-47a1-a994-76436a5cf20a&token=ODllMTRlMTQtZDlk</link>
      <guid isPermaLink="false">89e14e14-d9de-47a1-a994-76436a5cf20a</guid>
      <pubDate>Tue, 13 Jan 2026 02:59:55 +0000</pubDate>
      <category>Business Update</category>
      <description><![CDATA[<p>Netripples Software Ltd has reported no related party transactions for the 3rd quarter of the financial year 2025-26, as per the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. 2015 (&apos;Listing Regulations&apos;). This disclosure is of prominence as per the regulation for the financial year 2025-26. The same has been uploaded on the company&apos;s website.</p><ul><li>Netripples Software Ltd reports no related party transactions for the 3rd quarter of FY 2025-26</li><li>The disclosure is in accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. 2015 (&apos;Listing Regulations&apos;)</li><li>The same has been uploaded on the company&apos;s website for information and records</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/2392648d-f68a-4077-8d08-fe1a6457ca0e.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Netripples Software Ltd | Category: Business Update</small>]]></description>
    </item>
    <item>
      <title>[NETRIPPLES] Netripples Software Ltd Schedules Board Meeting on 21/01/2026 for Q3 Results</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Netripples+Software+Ltd&title=Netripples+Software+Ltd+Schedules+Board+Meeting+on+21%2F01%2F2026+for+Q3+Results&newsId=40186938-0ab1-4a0d-8455-374859e70c6f&token=NDAxODY5MzgtMGFi</link>
      <guid isPermaLink="false">40186938-0ab1-4a0d-8455-374859e70c6f</guid>
      <pubDate>Tue, 13 Jan 2026 02:54:57 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<p>Netripples Software Ltd, a company registered in Hyderabad, Telangana, has announced that its Board of Directors will meet on 21st January 2026 to consider and approve the unaudited financial results for the 3rd quarter of the financial year 2025-26. The meeting is scheduled to start at 11.00 am, and all directors have been informed and intimated to attend the board meeting in time.</p><ul><li>Netripples Software Ltd has scheduled a Board Meeting on 21st January 2026</li><li>The meeting aims to consider and approve the unaudited financial results for the 3rd quarter of the financial year 2025-26</li><li>The meeting is set to start at 11.00 am</li><li>All directors have been informed and intimated to attend the board meeting</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/cc45f14c-01a6-446e-9b44-ecdfd608a332.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Netripples Software Ltd | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[HCLTECH] HCL Technologies Ltd Changes Record Date for Interim Dividend Payment to January 17, 2026</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=HCL+TECHNOLOGIES+LTD.&title=HCL+Technologies+Ltd+Changes+Record+Date+for+Interim+Dividend+Payment+to+January+17%2C+2026&newsId=f8e25ce6-3436-4b4d-bfb5-e6fb7278b2f4&token=ZjhlMjVjZTYtMzQz</link>
      <guid isPermaLink="false">f8e25ce6-3436-4b4d-bfb5-e6fb7278b2f4</guid>
      <pubDate>Mon, 12 Jan 2026 20:31:06 +0000</pubDate>
      <category>Dividend</category>
      <description><![CDATA[<p>HCL Technologies Ltd has announced a change in the Record Date for the payment of Interim Dividend that was declared on January 12, 2026. The Record Date, which was initially fixed for January 16, 2026, has been shifted to January 17, 2026 due to a trading holiday announced on account of Municipal Corporation Elections in Maharashtra. The payment date remains unchanged at January 27, 2026.</p><ul><li>HCL Technologies Ltd changes Record Date for Interim Dividend payment</li><li>Record Date shifted from January 16, 2026 to January 17, 2026</li><li>Change due to a trading holiday on account of Municipal Corporation Elections in Maharashtra</li><li>Payment date remains unchanged at January 27, 2026</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/63740c0f-dca8-44b8-aeef-970f42d7fd35.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: HCL TECHNOLOGIES LTD. | Category: Dividend</small>]]></description>
    </item>
    <item>
      <title>[ICICIGI] ICICI Lombard General Insurance Company&apos;s Tax Litigation Appeals Allowed by CESTAT</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=ICICI+Lombard+General+Insurance+Company+Ltd&title=ICICI+Lombard+General+Insurance+Company%27s+Tax+Litigation+Appeals+Allowed+by+CESTAT&newsId=e281883b-1dc5-4c4c-b384-e34527b72b08&token=ZTI4MTg4M2ItMWRj</link>
      <guid isPermaLink="false">e281883b-1dc5-4c4c-b384-e34527b72b08</guid>
      <pubDate>Mon, 12 Jan 2026 17:51:22 +0000</pubDate>
      <category>Legal</category>
      <description><![CDATA[<p>ICICI Lombard General Insurance Company Ltd. has been informed that the appeals filed by the company with Central Excise and Service Tax Appellate Tribunal, Mumbai (CESTAT) for demand raised against the company for FY2008-09 to FY2011-12, FY2013-14 &amp; FY2014-15 and FY2011-12 have been allowed. The company is awaiting the copy of the appeal orders. This information will also be made available on the company&apos;s website.</p><ul><li>ICICI Lombard General Insurance Company&apos;s tax litigation appeals have been allowed by CESTAT.</li><li>The company is awaiting the copy of the appeal orders.</li><li>The information will be made available on the company&apos;s website.</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/1d3eed17-bb56-41c5-93d3-6af3fa9ba2c8.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: ICICI Lombard General Insurance Company Ltd | Category: Legal</small>]]></description>
    </item>
    <item>
      <title>[ICICIPRULI] ICICI Prudential Life Insurance Company Sells Entire Stake in ICICI Prudential Pension Funds Management to ICICI Bank</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=ICICI+Prudential+Life+Insurance+Company+Ltd&title=ICICI+Prudential+Life+Insurance+Company+Sells+Entire+Stake+in+ICICI+Prudential+Pension+Funds+Management+to+ICICI+Bank&newsId=1a601741-f622-4219-b618-22b1a4810c0b&token=MWE2MDE3NDEtZjYy</link>
      <guid isPermaLink="false">1a601741-f622-4219-b618-22b1a4810c0b</guid>
      <pubDate>Mon, 12 Jan 2026 17:31:21 +0000</pubDate>
      <category>Acquisitions</category>
      <description><![CDATA[<p>ICICI Prudential Life Insurance Company Ltd has sold its entire 100% equity shareholding in ICICI Prudential Pension Funds Management Company Limited to ICICI Bank Limited. The sale transaction was executed through a Share Purchase Agreement (SPA) on January 6, 2026. ICICI Bank now holds 100% shareholding in ICICI PFM, making it a wholly owned subsidiary of ICICI Bank.</p><ul><li>ICICI Prudential Life Insurance Company sells its entire stake in ICICI Prudential Pension Funds Management to ICICI Bank.</li><li>The sale transaction was executed through a Share Purchase Agreement (SPA) on January 6, 2026.</li><li>ICICI Bank now holds 100% shareholding in ICICI PFM.</li><li>ICICI PFM has become a wholly owned subsidiary of ICICI Bank.</li><li>The transaction was worth 2.035 billion based on fair value determined by an independent valuer.</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/d87d507d-3183-47b3-b58c-e3db78c35446.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: ICICI Prudential Life Insurance Company Ltd | Category: Acquisitions</small>]]></description>
    </item>
    <item>
      <title>[ZELIO] Zelio E-Mobility&apos;s Q3 Revenue Surges 67%, Capacity Expanded by 70%</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Zelio+E+Mobility+Ltd&title=Zelio+E-Mobility%27s+Q3+Revenue+Surges+67%25%2C+Capacity+Expanded+by+70%25&newsId=f646b016-f8e8-45e4-8615-6069accd6541&token=ZjY0NmIwMTYtZjhl</link>
      <guid isPermaLink="false">f646b016-f8e8-45e4-8615-6069accd6541</guid>
      <pubDate>Mon, 12 Jan 2026 17:24:30 +0000</pubDate>
      <category>Quarterly Result</category>
      <description><![CDATA[<strong>ðŸ”¥ Trending</strong><br/><p>Zelio E-Mobility Limited, a leading player in the slow-speed electric vehicle (EV) segment in India, reported a strong operational and financial performance for the quarter ended 31 December 2025. The company recorded a 67% year-on-year revenue growth in Q3 FY 2025-26, driven by robust festive demand, an expanding dealer footprint, increasing brand acceptance in Tier-2 and Tier-3 markets, and disciplined execution. The company&apos;s revenue increased from â‚¹29.6 crore in Q1 FY 2024-25 to â‚¹291.6 crore in Q3 FY 2025-26. Zelio also expanded its existing capacity by 70% to over 1,20,000 units per annum with a projected FY 2025-26 capacity utilization of 85%.</p><ul><li>Q3 revenue growth of 67%</li><li>Existing capacity expanded by 70% to over 1,20,000 units per annum</li><li>Strong Diwali season performance with 13,566 units sold (up 74% YoY) and revenue of â‚¹59 crore (up 64% YoY)</li><li>Proposed Odisha manufacturing facility targeted to commence commercial operations from February 2026</li><li>Evaluation of a potential manufacturing / assembly facility in Southern India</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/2876fd3d-0897-4e3d-9161-4b1466d6fd74.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Zelio E Mobility Ltd | Category: Quarterly Result</small>]]></description>
    </item>
    <item>
      <title>[POONAWALLA] Poonawalla Fincorp Ltd Schedules Board Meeting to Consider Fund Raising of up to Rs. 20,000 Crore</title>
      <link>https://www.stockwatch.live/news?showModal=true&name=Poonawalla+Fincorp+Ltd&title=Poonawalla+Fincorp+Ltd+Schedules+Board+Meeting+to+Consider+Fund+Raising+of+up+to+Rs.+20%2C000+Crore&newsId=cb402ab5-6a44-49a1-a864-c5f46dd03e92&token=Y2I0MDJhYjUtNmE0</link>
      <guid isPermaLink="false">cb402ab5-6a44-49a1-a864-c5f46dd03e92</guid>
      <pubDate>Mon, 12 Jan 2026 17:11:17 +0000</pubDate>
      <category>Investment</category>
      <description><![CDATA[<p>Poonawalla Fincorp Ltd has informed the BSE that the company&apos;s Board of Directors will meet on 16/01/2026. The agenda includes considering and approving an intimation under Regulation .... The Board will also consider raising funds by issuing equity shares of the company on qualified institutions placement and/or through any other permissible mode. The fundraising could be up to Rs. 20,000 Crore through the issuance of Non-Convertible Debt Securities on a private placement basis during the Financial Year 2026-2027. The Trading Window will remain closed till Sunday, January 18, 2026, as per the Companyâ€™s â€˜Code of Conduct for Prohibition of Insider Tradingâ€™.</p><ul><li>Poonawalla Fincorp Ltd board meeting scheduled for 16/01/2026</li><li>Consideration of intimation under Regulation ....</li><li>Potential fundraising through equity shares issuance</li><li>Potential fundraising of up to Rs. 20,000 Crore through Non-Convertible Debt Securities</li><li>Trading Window closure till Sunday, January 18, 2026</li></ul><p>ðŸ“„ <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/0d4723ca-8144-4695-9e2f-9e90b7be8b91.pdf">Read Official Filing (PDF)</a></p><br/><small>Company: Poonawalla Fincorp Ltd | Category: Investment</small>]]></description>
    </item>
  </channel>
</rss>